Rational design of sequestering agents for plutonium and other actinides.
about
A protein engineered to bind uranyl selectively and with femtomolar affinityFunctional sorbents for selective capture of plutonium, americium, uranium, and thorium in bloodSynthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: Developing a structure–activity relationship1,2-hydroxypyridonate/terephthalamide complexes of gadolinium(III): synthesis, stability, relaxivity, and water exchange properties.Zinc-binding groups modulate selective inhibition of MMPs.Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).Desferrithiocin analogue uranium decorporation agents.Novel sorbents for removal of gadolinium-based contrast agents in sorbent dialysis and hemoperfusion: preventive approaches to nephrogenic systemic fibrosis.Biomimetic actinide chelators: an update on the preclinical development of the orally active hydroxypyridonate decorporation agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO).Design of iron chelators with therapeutic application.Characterization, HPLC method development and impurity identification for 3,4,3-LI(1,2-HOPO), a potent actinide chelator for radionuclide decorporation.New Synthetic Approach for the Incorporation of 3,2-Hydroxypyridinone (HOPO) Ligands: Synthesis of Structurally Diverse Poly HOPO Chelators.Oligopyrrole macrocycles: receptors and chemosensors for potentially hazardous materials.Interaction of Cm(III) and Am(III) with human serum transferrin studied by time-resolved laser fluorescence and EXAFS spectroscopy.Metalloprobes: synthesis, characterization, and potency of a novel gallium(III) complex in human epidermal carcinoma cellsComplexation of Cm(III) with the recombinant N-lobe of human serum transferrin studied by time-resolved laser fluorescence spectroscopy (TRLFS).Chemical and biological insights into uranium-induced apoptosis of rat hepatic cell line.Probing chelation motifs in HIV integrase inhibitorsImproved deposition and deprotection of silane tethered 3,4 hydroxypyridinone (HOPO) ligands on functionalized nanoporous silicaAn iron-dependent and transferrin-mediated cellular uptake pathway for plutonium.Preparation of 3-benzyloxy-2-pyridinone functional linkers: Tools for the synthesis of 3,2-hydroxypyridinone (HOPO) and HOPO/hydroxamic acid chelators.New methodology for the preparation of 3-hydroxy-2-pyridinone (3,2-HOPO) chelators and extractants. Part 2. Reactions of alcohols, phenols, and thiols with an electrophilic 3,2-HOPO reagent()Synthetic approaches to mixed ligand chelators on t-butylphenol-formaldehyde oligomer (PFO) platforms.Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for (89)Zr(4+) and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice.Dose-dependent efficacy and safety toxicology of hydroxypyridinonate actinide decorporation agents in rodents: towards a safe and effective human dosing regimen.A proteomic approach to identification of plutonium-binding proteins in mammalian cellsp-SCN-Bn-HOPO: A Superior Bifunctional Chelator for (89)Zr ImmunoPETDesferrithiocin analogues and nephrotoxicity.Reactions of N-benzyloxycarbamate derivatives with stabilized carbon nucleophiles: a new synthetic approach to polyhydroxamic acids and other hydroxamate-containing mixed ligand systemsRadiobiological basis in management of accidental radiation exposure.Design of clinically useful macromolecular iron chelators.Catechol-based biomimetic functional materials.3-Hydroxypyridinone derivatives as metal-sequestering agents for therapeutic use.1,2-HOIQO--a highly versatile 1,2-HOPO analogue.Investigation of the complexation of natZr(iv) and 89Zr(iv) by hydroxypyridinones for the development of chelators for PET imaging applications.Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators.Mass spectrometry-derived systems biology technologies delineate the system's biochemical applications of siderophores.Synthesis of Carboxylic Acids and Esters from CO2.Relativistic DFT and experimental studies of mono- and bis-actinyl complexes of an expanded Schiff-base polypyrrole macrocycle.89Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89Zr Radiochemistry.
P2860
Q27689318-4D7CB03C-D14A-4763-8958-131DE5BCEEACQ28382820-8C05451B-FC3C-469B-BB3F-76F7FE2F0BAAQ29012564-3ABE3938-37BB-4BF1-B884-C66D28BC1845Q33386980-C2A07DFB-89DA-4CBA-8DDB-9C2AFFB5D4E6Q33718245-6B8D80F1-EB48-4508-B5FD-F56327331B3CQ33761754-4BF661F1-4B34-49E9-89F1-98F125A69910Q33818209-AA7E6C23-0513-4C14-80DA-CB87E6C4DD2FQ33822402-2C1FD19E-AAC5-4A94-8CAE-9B24535EAA87Q34064275-74ADAE74-945A-49AA-B47E-2F0C38F969DFQ34258805-9C160A42-341A-440A-A3D2-B6AFCC05475AQ35039838-AB32CC64-57E0-4AF2-8A5C-00432FC46EF1Q35060340-48DD298F-912F-4F61-8516-2BFE48C7694EQ35097638-A701626D-6FFF-4609-ACB5-39E7EC5D34DEQ35120280-C489D276-FC63-42BE-B664-3746831A6AC4Q35147021-27ADEB47-A7A2-47A7-8433-667D490A9BBCQ35497878-5DCE3F05-E4C0-451C-ADA7-4C48E5394C12Q35552120-49266729-2BFF-436C-AA9F-3C2EBB244243Q35786972-4CE740C6-3017-4EFD-A6AE-B1C71A95BF6EQ36197931-162DAE86-D6D4-4F3D-A483-F92D41D25846Q36292738-3B150DC9-8376-4A1D-BBC7-5E12CCF97480Q36333948-A8B454B9-A3F5-4C63-B2F7-70B1AE3526A9Q36399670-3618A3FF-7870-44F3-921B-5EA64F30C0EBQ36443862-0205D513-A181-48BC-9E17-06BDF8E08E1FQ36644332-1C1B5D9D-8C31-46B8-B140-7EC5E6892B20Q36787963-2553EE7E-293B-4F38-813C-16310024BD7EQ36944589-7DD57AD5-5195-4BF6-815D-424BBDFEE715Q37129847-D8550C24-D91A-4589-90DD-56E6A148EFF2Q37423512-EE45A194-A0AC-4DBF-B1E7-2CC1E73A56F2Q37446333-F26151AF-8F41-459D-96AA-2F9099AE5D44Q37776732-CC04F3AC-1692-429F-AB16-157C002744ADQ37884088-F3BEF645-0242-46E4-B722-A91DCD0B7AC0Q38062517-AA22F2B7-5CD8-435F-8DDF-4F2A95905F0CQ38397352-0539BDB3-6207-479E-AC11-B8961C78CCAAQ38675811-68A8F92B-8F96-454E-8632-4206D8CF9C92Q38880203-582EEB6E-ECE1-46F7-98B1-E8620E845637Q38898546-0CE26760-91E5-4C91-9EFC-7ECD83CB0B88Q38942299-0F4FE7C2-6961-463B-84D1-B51C58EE9445Q39037226-C625B404-7DD0-4658-A1A3-EF06979BB7A2Q39635913-54F81B47-8DE8-42C4-90EA-477F6D4ADAECQ41690954-DDEE1471-2181-40DF-BEFD-F49E9A800278
P2860
Rational design of sequestering agents for plutonium and other actinides.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Rational design of sequestering agents for plutonium and other actinides.
@ast
Rational design of sequestering agents for plutonium and other actinides.
@en
type
label
Rational design of sequestering agents for plutonium and other actinides.
@ast
Rational design of sequestering agents for plutonium and other actinides.
@en
prefLabel
Rational design of sequestering agents for plutonium and other actinides.
@ast
Rational design of sequestering agents for plutonium and other actinides.
@en
P2093
P356
P1433
P1476
Rational design of sequestering agents for plutonium and other actinides
@en
P2093
Kenneth N Raymond
Patricia Durbin
P304
P356
10.1021/CR990114X
P577
2003-11-01T00:00:00Z